Imaging of the parathyroid in chronic renal failure: Diagnostic and therapeutic aspects

Current Opinion in Nephrology and Hypertension

Volumn 6, Issue 4, 1997, Pages 349-355

  Fukagawa, Masafumi ^a   Kitaoka, Masafumi ^b   Inazawa, Takeshi ^b   Kurokawa, Kiyoshi ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b Showa General Hospital   (Japan)

^c TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIALYSIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROID GLAND EXAMINATION; PARATHYROID HYPERPLASIA; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REVIEW; SECONDARY HYPERPARATHYROIDISM; UREMIA;

EID: 0030740190     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199707000-00007     Document Type: Review

References (74)

1. Coburn JW, Llach F: Renal osteodystrophy. In Clinical Disorders of Fluid and Electrolyte Metabolism, 5th edn. Edited by Narins RG. New York: McGraw Hill Book Co.; 1994:1299-1377.
2. Parfitt AM: Parathyroid growth: normal and abnormal. In The Parathyroids: Basic & Clinical Concepts. Edited by Bilezikian JP, Marcus R, Levine MA. New York: Raven Press; 1994:373-406.
3. Drüeke TB: The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int 1993, 48:259-272.
4. Arnold A: Genetic basis of endocrine disease 5: molecular genetics of parathyroid gland neoplasia. J Clin Endocrinol Metab 1993, 77:1108-1112.
5. Akizawa T, Fukagawa M, Koshikawa S, Kurokawa K: Recent progress in management of secondary hyperparathyroidism of chronic renal failure. Curr Opin Nephrol Hypertens 1993, 2:558-565.
6. Mitchell BK, Merrell RC, Kinder BK: Localization studies in patients with hyperparathyroidism. Surg Clin North Am 1995, 75:483-499.
7. Mazzeo S, Caramella D, Lencioni R, Molea N, De Liperi A, Marcocci P, Iacconi P, Bossio GB, Viacava P, Lazzeri E, Bartolozzi C: Comparison among sonography, double-tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions. AJR 1996, 166: 1465-1470. This is a recent comparison study of imaging in primary hyperparathroidism. Sensitivity of sonography and scintigraphy was equal. The authors suggest that sonography should be used as the first line of abnormal parathyroid glands, and Tc-MIBI scintigraphy as the second.
8. Vojvodich SM, Lampe HB: Imaging and surgery in hyperparathyroidism: a 10-year review. J Otolaryngeol 1996, 25:126-129.
9. Light VL, McHenry CR, Jarjoura D, Sodee DB, Miron SD: Preoperative comparison of dual-phase technetium-99m-sestamibi scintigraphy and high resolution ultrasonography in the evaluation of abnormal parathyroid glands. Am Surg 1996, 62:562-568.
10. Coakley AJ: Parathyroid Imaging. Nucl Med Commun 1995, 16:522-533.
11. Yousem DM, Scheff AM: Thyroid and parathyroid gland pathology: role of imaging. Otolaryngeol Clin North Am 1995, 28:621-649.
12. Hopkins CR, Reading CC: Thyroid and parathyroid imaging. Semin Ultrasound CT MRI 1995, 16:279-295.
13. Giron J, Ouhayoun E, Dahan M, Berjaud J, Esquerre JP, Senac JP, Railhac JJ: Imaging of hyperparathyroidism: US, CT, MRI and MIBI scintigraphy. Eur J Radiol 1996, 21:167-173.
14. Miller DL: Pre-operative localization and interventional treatment of parathyroid tumors: when and how? World J Surg 1991, 15:706-715.
15. Russell CF, Laird JD, Ferguson WR: Scan-directed unilateral cervical exploration for parathyroid adenoma: a legitimate approach? World J Surg 1990, 406-409.
16. Rodriguez JM, Tezelman S, Siperstein AE, Duh QY, Higgins C, Morita E, Dowd CF, Clark OH: Localization procedures in patients with persistent or recurrent hyperparathyroidism. Arch Surg 1994, 129:870-875.
17. Casas AT, Burke GL, Mansberger AR Jr, Wei JP: Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism. Am J Surg 1994, 60:12-17.
18. Roe SM, Burns RP, Graham LD, Brock WB, Russell WL: Cost-effectiveness of preoperative localization studies in primary hyperparathyroid disease. Ann Surg 1994, 219:582-586.
19. Koosman M: Parathyroidectomy in chronic renal failure. Am J Surg 1994, 168:631-634.
20. Rothmund M, Wagner PK, Schark C: Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism. World J Surg 1991, 15:745-50.
21. Mallette LE, Malini S: The role of parathyroid ultrasonography in the management of primary hyperparathyroidism. Am J Med Sci 1989, 298:51-58.
22. Gladziwa U, Ittel TH, Dakshinamurty KV, Schacht B, Riehl J, Sieberth HG: Secondary hyperparathyroidism and sonographic evaluation of parathyroid gland hyperplasia in dialysis patients. Clin Nephrol 1992, 38:162-166.
23. Solbiati L, Cioffi V, Ballarati E: Ultrasonography of the neck. Radiol Clin North Am 1992, 30:941-954.
24. McCarron DA, Muther RS, Lenfesty B, Bennett WM: Parathyroid function in persistent hyperparathyroidism: relationship to gland size. Kidney Int 1982, 22:662-670.
25. Fukagawa M, Kitaoka M, Yi H, Fukuda N, Matsumoto T, Ogata E, Kurokawa K: Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 1994, 68:221-228.
26. Tominaga Y, Takagi H: Molecular genetics of hyperparathyroid disease. Curr Opin Nephrol Hypertens 1996, 5:336-341.
27. Tominaga Y, Tanaka Y, Sato K, Nagasaka T, Takagi H: Histopathology, pathophysiology and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 1997, 13:78-86.
28. Tominaga Y, Sato K, Tanaka Y, Numano M, Uchida K, Takagi H: Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure. Clin Nephrol 1995, 44(suppl):42-47.
29. Tominaga Y, Grimelius L, Falkmer UG, Johansson H, Falkmer S: DNA ploidy pattern of parathyroid parenchymal cells in renal secondary hyperparathyroidism with relapse. Anal Cell Pathol 1991, 3:325-333.
30. Tominaga Y, Tanaka Y, Sato K, Numano M, Uchida K, Falkmer U, Grimelius L, Johansson H, Takagi H: Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 1992, 16:595-603.
31. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993, 92:1436-1443.
32. Arnold A, Brown MF, Urena P, Gaz RD, Sarfati E, Drüeke TB: Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995, 95:2047-2053.
33. Tominaga Y, Kohara S, Namii Y, Nagasaka T, Haba T, Uchida K, Numano M, Tanaka Y, Takagi H: Clonal analysis of nodular hyperplasia in renal hyperparathyroidism. World J Surg 1996, 20744-752. By extracting DNA from each nodule, the authors confirmed monoclonal cell proliferation even in small nodule formation in abnormal parathyroid.
34. Falchetti A, Bale AE, Amorosi A, Bordi C, Cicchi P, Bandini S, Marx SJ, Brandi ML: Progression of uremic hyperparathyroidism involves alleic loss on chromosome 11. J Clin Endocrinol Metab 1993, 76:139-144.
35. Fukagawa M, Fukuda N, Yi H, Kurokawa K: Resistance to calcitriol as a cause of parathyroid hyperfunction in chronic renal failure. Nephrol Dial Transplant 1995, 10:316-319.
36. Wolf RJ, Cronan JJ, Monchik JM: Color Doppler sonography: an adjunctive technique in assessment of parathyroid adenomas. J Ultrasound Med 1994, 13:303-308.
37. Moinuddin M, Whynott C: Ectopic parathyroid adenomas: multi-imaging modalities and its management. Clin Nucl Med 1996, 21:27-32.
38. Cannella G, Bonucci E, Rolla D, Ballanti P, Moriero E, De Grandi R, Augeri C, Claudiani F, Di Maio G: Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol. Kidney Int 1994, 46:1124-1132.
39. Coakley AJ, Kettle AG, Wells CP, O'Doherty MJ, Collins REC: Technetium-99m-sestamibi - a new agent for parathyroid imaging. Nucl Med Commun 1989, 10:791-794.
40. Chiu ML, Kronange JF, Piwnica-Worms D: Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium in culture mouse fibroblasts. J Nucl Med 1990, 31:1646-1653.
41. O'Doherty MJ, Kettle AG, Wells PC, Collins REC, Coakley AJ: Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1992, 33:313-318.
42. Tsukamoto E, Russell CFJ, Ferguson WR, Laird JD: The role of preoperative technetium subtraction scintigraphy in the surgical management of patients with solitary parathyroid adenoma. Clin Radiol 1995, 56:677-680.
43. Caixas A, Berna L, Piera J, Rigla M, Matias-Guiu, Farrerons J, Puig-Domingo M: Utility of 99mTc-sestamibi scintigraphy as a first-line imaging procedure in the preoperative evaluation of hyperparathyroidism. Clin Endocrinol 1995, 43:525-530.
44. McHenry CR, Lee K, Saadey J, Neumann DR, Esselstyn CB: Parathyroid localization with technetium-99m-sestamibi: a prospective evaluation. J Am Coll Surg 1996, 183:25-30.
45. Sofferman, Narham MH, Fairbink JT: Preoperative technetium Tc 99m sestamibi imaging: paving the way to minimal-access parathyroid surgery. Arch Otolaryngeol Head Neck Surg 1996, 122:369-374.
46. 99mTc-MIBI scintigraphy. Furthermore, they found significant positive correlation between gland size and PTH level in MIBI-positive patients.
47. Kilgore EJ, Teigen EL, Cowan RJ: Imaging of transplanted parathyroid tissue in a patient with recurrent hyperparathyroidism. Clin Nucl Med 1996, 21:383-386.
48. Schurrer ME, Seabold JE, Gurll NJ, Simonson TM: Sestamibi SPECT scintigraphy for detection of postoperative hyperfunctional parathyroid glands. AJR 1996, 166:1471-1474. See [49•].
49. 99mTc-sestamibi single-photon emmission computed tomography. This is a new sensitive method for anatomical localization of aberrant hyperfunctioning parathyroid glands.
50. Burke GJ Wei JP, Binet EF: Parathyroid scintigraphy with iodine 123 and 99mTc-sestamibi: imaging findings. AJR 1993, 161:1265-1268.
51. Kohri K, Ishikawa Y, Kodama M, Katayama Y, Iguchi M, Yachiku S, Kurita T Comparison of imaging methods for localization of parathyroid tumors. Am J Surg 1992, 164:140-145.
52. Higgins CB: Role of magnetic resonance imaging in hyperparathyroidism. Radiol Clin North Am 1993, 31:1017-1028.
53. McDermott VG, Fernandez RJM, Meakem III TJ, Stolpen AH, Spritzer CE, Gefter WB: Preoperative MR imaging in hyperparathyroidism: results and factors affecting parathyroid detection. AJR 1996, 705-710. This is a large-scale study on the sensitivity of MRI for abnormal parathyroid. The authors demonstrated the high sensitivity of MRI and its pitfalls as well.
54. Stevens SK, Chang JM, Clark OH, Chang PJ, Higgins CB: Detection of abnormal parathyroid glands in postoperative patients with recurrent hyperparathyroidism: sensitivity of MR imaging. AJR 1993, 160:607-612.
55. Wright AR, Goddard PR, Nicholson S, Kinsella DC, Davies ER, Farndon JR: Fat suppression magnetic resonance imaging in the preoperative localization of parathyroid adenomas. Clin Radiol 1992, 46:324-328.
56. Seelos KC, DeMarco R, Clark OH, Higgins CB: Persistent and recurrent hyperparathyroidism: assessment with gadopentetate dimeglumine-enhanced MR imaging. Radiology 1990, 177:373-378.
57. Miller DL, Doppmann JL, Chang R, Simmons JT, O'Leary TJ, Norton JA, Spiegel AM, Marx SJ, Aurbach GD: Angiographic ablation of parathyroid adenomas: lessons from 10 year experience. Radiology 1987, 165:601-607.
58. Pollotta JA, Sacks BA, Moller DE, Eisenberg H: Arteriographic anlation of cervical parathyroid adenomas. J Clin Endocrinol Metab 1989, 62:1249-1255.
59. Miller DL: Endocrine angiography and venous sampling-hyperparathyroidism. Radiol Clin North Am 1993, 31:1055-1067.
60. Fukagawa M, Kitaoka M, Kurokawa K: Ultrasonographic intervention of parathyroid hyperplasia in chronic dialysis patients: A theoretical approach. Nephrol Dial Transplant 1996, 11(suppl 3):125-129.
61. Clements RH, Kent RB III: Preoperative needle-localized parathyroidectomy for persistent secondary hyperparathyroidism. Am Surg 1996, 62:413-415.
62. Solbiati L, Giangrande A, Pra LD, Belloti E, Cantu P, Ravetto C: Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Radiology 1985, 155:607-610.
63. Giangrande A, Casliglioni A, Sorbiati L, Allaria P: Ultrasound guided percutaneous fine needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant 1992, 7:412-421.
64. Karstrup S, Transbol I, Holm HH, Glenthoi A, Hegedus L: Ultrasound-guided chemical parathyroidectomy in patients with primary hyperparathyroidism. Br J Radiol 1989, 62:1037-1042.
65. Karstrup S, Holm HH, Glenthoi A, Hegedus L: Nonsurgical treatment of primary hyperparathyroidism with sonographically guided percutaneous injection of ethanol: Results in a selected series of patients. AJR 1990, 154:1087-1090.
66. Kitaoka M, Fukagawa M, Ogata E, Kurokawa K: Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients. Kidney Int 1994, 46:1110-1117.
67. Kitaoka M, Fukagawa M, Kurokawa K: Direct injection of calcitriol into parathyroid hyperplasia in chronic dialysis patients with severe parathyroid hyperfunction. Nephrology 1995, 1:563-568.
68. Slatopolsky EA, Weerts C, Thielan J, Horst R, Harter H, Martin KJ: Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 1984, 74:2136-2143.
69. 3 in experimental renal hyperparathyroidism. Kidney Int 1993, 44:1259-1265.
70. 3 in the parathyroid in vivo. J Clin Invest 1990, 86:1968-1975.
71. Fukuda N, Katoh T, Yi H, Fukagawa M, Saito I, Kanegae Y, Chang H, Kurokawa K: Successful in vivo gene transfer into parathyroid glands with adenovlral vector delivered by selective injection in rats [Abstract]. J Am Soc Nephrol 1995, 6:961.
72. Doppman JL, Krudy AG, Marx SJ, Saxe A, Schneider P, Norton JA, Spiegel AM, Downs RW, Schaaf M, Brennen ME et al.: Aspiration of enlarged parathyroid glands for parathyroid hormone assay. Radiology 1983, 148:31-35.
73. Karstrup S, Glenthoj A, Hainau B, Torp-Pedersen S, Hegedus L, Holms HH: Ultrasonographically guided, histological, fine-needle biopsy from suspect parathyroid tumors: success rate and reliability of histological diagnosis. Br J Radiol 1989, 62:981-985.
74. Fukagawa M, Kitaoka M, Fukuda N, Yi H, Kurokawa K: Pathogenesis and management of parathyroid hyperplasia in chronic renal failure: role of calcitriol. Mineral Electrolyte Metab 1995, 21:97-100.